Understand the importance of targeted assays in personalised medicine and how early decisions shape clinical outcomes.

One recent obstacle to drug delivery research is an observed weak correlation between in vitro and in vivo performance. When nanoparticles are applied intravenously, they face several obstacles that ...

insights from industryNatalie Strickland Global Head of Translational ScienceSynexa Life Sciences In this interview, News Medical speaks with Natalie Strickland, Global Head of Translational Science ...

Dr. Markus Gershater explains how High Dimensional Experimentation (HDE) revolutionizes assay development by replacing one-factor-at-a-time (OFAT) methods with automated, multivariate workflows.

Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...

Multiplex assay tech detects multi-biomolecules in single samples on xMAP/CBA, with high sensitivity and consistency ...

Targeted Protein Degradation (TPD) is an emerging drug modality that enables specific degradation of protein targets, offering a powerful approach to tackle previously undruggable targets including ...